Life Sciences

Industries Life Sciences

TGS Baltic “impresses sources with its full-service capability and strength in multi-jurisdictional deals. […] The firm has been very active representing clients against state authorities.” 

We believe life and health are humanity's greatest values. And we are here to protect and secure businesses that promote and develop those values. Our multidisciplinary life sciences team integrates legal, medical and scientific expertise to help clients develop their businesses in the times of technological, reputational, ethical, data management, patent, and personal challenges.

We understand this market and its milestones, including the importance of R&D and how fierce competition is both globally and locally. We also know that strategic legal solutions need to reflect a knowledge of business effectiveness.

TGS Baltic's life science practice has unique experience in national and international healthcare regulation. The team has helped healthcare providers in the Baltic region, Great Britain and Northern Europe to implement new organizational models that ensure top international standards of care. 

Some of the world’s largest and most innovative pharmaceutical companies, ranked as market leaders by Forbes, put their trust in us.

Major Deals

  • 14.05.2019

    Advising TBD-Biodiscovery on involving a Dutch investor from SEAL Investments B.V.

    TGS Baltic's team, led by partner Leonid Tolstov, advised the leading Estonian biotechnology company TBD-Biodiscovery and its sole shareholder on involving a Dutch investor from SEAL Investments B.V., who acquired 30% of the company's shares and will be investing a total of EUR 4.5 million in the company in the next few years. This is one of the largest foreign investments in an Estonian biotechnology company.

    More
  • 01.01.2019

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline, a science-led global healthcare company. We advised Client on a Pan-Baltic level in a project related to development of internal public procurement policies, ebracing the best practices for various corporate and public procurement issues, including but not limited to protection of confidencial information, fair competition and proper participation in tender produres and etc. These policies reflected boath national regulation and case law, as well as the case law of the European Court of Justice and provisions of the EU public procurement directives.

  • 04.03.2018

    TGS Baltic advised VIKONDA Group, one of the biggest business groups in Lithuania

    TGS Baltic advised VIKONDA Group (VIKONDA Concern), one of the biggest business groups in Lithuania with significant interests in food, trade, crop, media industries, construction, and other services, with a consolidated annual turnover of approximately EUR 145 million, on a complex holding restructuring.

     

    More
  • 11.09.2017

    TGS Baltic assisted BENU Aptieka Latvija SIA with acquisition of 100% of share of SIA Cēsu Vecpilsētas Aptieka

    Andra Rubene, Attorney at Law, Partner, and Rūdolfs Vilsons, Associate at TGS Baltic assisted BENU Aptieka Latvija SIA, one of the leading retail of medicines chains in the Baltics, with acquisition of 100% shares SIA Cēsu Vecpilsētas Aptieka, a pharmacy in Cēsis, Latvia from a number of private persons, thereby expanding Benu network of more than 66 pharmacies in Latvia.

    More
  • 01.01.2017

    Eugenija Sutkienė awarded as Market Maker for Lithuania

    On 1 June 2017, at a special awards ceremony at the Intercontinental Hotel in Warsaw, Eugenija Sutkienė was named the Market Maker for Lithuania, which is a special lifetime achievement award given to a senior lawyer identified by peers as having played the most influential and significant role in creating the country’s modern legal market

    More
  • 29.09.2016

    Advising Viru Haigla on the acquisition of Karell Kiirabi

    The firm’s M&A team led by associate partner Sander Kärson advised the strategic investor Viru Haigla on the acquisition of Karell Kiirabi from U.S. Invest.

    More

Team

Key Contacts